← Open Payments lookup

JARRA GREEN-CALDERON: Open Payments

NPI 1659516615 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,129 in 59 payments from 13 companies in 2025. Trend: 2023 $3,504 · 2024 $2,137 · 2025 $4,129

Travel & lodging: $2,171Food & beverage: $1,916Education: $43
CompanyPaymentsAmount
Eli Lilly and Company14$2,372
Tandem Diabetes Care, Inc.5$377
Dexcom, Inc.10$217
Novo Nordisk Inc7$211
Corcept Therapeutics8$160
AstraZeneca Pharmaceuticals LP3$155
CeQur Corporation1$153
Neurocrine BioSciences, Inc.1$134
Madrigal Pharmaceuticals1$132
Boehringer Ingelheim Pharmaceuticals, Inc.3$74

Products named: t:slim X2 Insulin Pump with Control-IQ, Korlym, FARXIGA, CeQur Simplicity, Ozempic, CRENESSITY, REZDIFFRA, DEXCOM G7 GSS (161).

Industry payments across TX — which companies pay providers there.